Table 1 (abstract P199). Demographics and clinical characteristics by immune status
From: Proceedings of the 25th European Paediatric Rheumatology Congress (PReS 2018)
| Â | Non-immune (n=414) | Immune (n=178) | P-value |
|---|---|---|---|
Age (y) | |||
 7-10 years | 30 (7%) | 20 (11%) | 0.00 |
 11-15 years | 129 (31%) | 39 (22%) | |
 16-20 years | 188 (46%) | 73 (41%) | |
 > 20 years | 67 (16%) | 46 (26%) | |
Biologic* | |||
 Anti TNF | 310 (75%) | 139 (78%) | 0.95 |
 Anti IL-6 | 42 (10%) | 12 (7%) | 0.44 |
 Anti IL-1 | 16 (4%) | 3 (2%) | 0.29 |
 Anti T-cell | 35 (8%) | 11 (6%) | 0.60 |
 Anti B-cell | 14 (3%) | 14 (8%) | 0.00 |
 Others | 9 (2%) | 1 (1%) | 0.20 |